Newsletter Subject

[Alert] Two Smart-Money Plays On Watch

From

biotechbreakouts.com

Email Address

Kyle@Biotechbreakouts.com

Sent On

Sun, Dec 6, 2020 08:38 PM

Email Preheader Text

, I don’t stay on the sidelines… I actually turn to my “insider” activity scanne

[image] Dear Trader, There’s a major catalyst on the table this week, and it may shake up some sectors. No doubt about it, there will be plenty of traders with eyes on the Pfizer-BioNTech advisory committee meeting on Dec. 10. [When there’s a catalyst of this nature](, I don’t stay on the sidelines… I actually turn to my “insider” activity scanner to try to uncover smart money plays. You see, these Wall street whales are throwing down some pretty sizable bets… And my thought process is that chances are no one is placing trades of this magnitude if they’re not well-informed. I’m sure you can probably guess how much easier it is to [take the smart money’s trade ideas and make them your own,]( than trying to find plays on your own. That said, let me show you two names that saw unusual options activity last week. [Click here to continue reading…]( [image] Kyle Dennis P.S. On Wednesday, Dec. 9 at 2 PM ET, Nathan Bear reveals [The “Unbreakable” Pattern]( — and how it helped him turn the corner as a trader. In this rare live event, you’ll hear how this one single strategy took Nathan from $40K in trading losses to nearly $4M in career trading gains. [This is one training session you do not want to miss out on](… especially if you’re serious about learning how to put yourself in a position to make money in the market.  Remove me from Biotech Breakouts Free Newsletter  [Click here to unsubscribe and stop receiving exclusive emails from kyle@biotechbreakouts.com]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at . FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. Click [Unsubscribe]( To Unsubscribe From All RagingBull Emails 62 Calef Hwy #233 Lee, New Hampshire 03861 United States

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.